CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Oct. 25, 2014	Oct. 26, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 3,879	$ (6,831)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	5,903	5,105
Non-cash share-based compensation	790	800
Deferred taxes	(809)	(4,690)
Provision to value inventories at LIFO	100	150
Changes in assets and liabilities:
Merchandise inventories	(633)	(964)
Patronage dividend receivable	(4,293)	(4,189)
Accounts payable to Wakefern	(5,336)	(4,244)
Accounts payable and accrued expenses	(1,835)	(1,025)
Accrued wages and benefits	(3,085)	(2,270)
Income taxes payable	2,819	17,679
Other assets and liabilities	2,551	(1,736)
Net cash provided by (used in) operating activities	51	(2,215)
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(4,386)	(16,520)
Investment in notes receivable from Wakefern	(410)	(396)
Net cash used in investing activities	(4,796)	(16,916)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	13	217
Excess tax benefit related to share-based compensation	7	46
Principal payments of long-term debt	(232)	(163)
Dividends	(3,133)	(3,080)
Net cash used in financing activities	(3,345)	(2,980)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(8,090)	(22,111)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	77,352	109,571
CASH AND CASH EQUIVALENTS, END OF PERIOD	69,262	87,460
SUPPLEMENTAL DISCLOSURES OF CASH PAYMENTS MADE FOR:
Interest	1,082	1,025
Income taxes	1,498	0
NONCASH SUPPLEMENTAL DISCLOSURES:
Investment in Wakefern	$ 738	$ 657